PERSPECTA

News from every angle

← Back to headlines

ANI Pharmaceuticals Reports Strong Q2 Earnings and Revenue Beat

ANI Pharmaceuticals announced Non-GAAP EPS of $2.21, surpassing estimates by $0.17, and revenue of $266.04 million, beating forecasts by $5.91 million.

7 Aug, 10:53 — 7 Aug, 10:53
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed8d ago

ANI Pharmaceuticals Non-GAAP EPS of $2.21 beats by $0.17, revenue of $266.04M beats by $5.91M

Read full article →

Related Stories

Bijelo Polje Company and Turkish Citizen Face Tax Evasion Charges

1h ago

Inland Shipping Industry Faces Low Water Crisis on Rhine

2h ago

Yugo Road Trip Documentary and Economic Insecurity Film Screen at Sarajevo Film Festival

3h ago

Proposal to Bypass Strait of Hormuz with Oil Pipeline Through Syria

3h ago